You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,412,462


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,412,462
Title:Methods and systems for processing genomic data
Abstract: A computer implemented method may be used to receive a sequence of binary codes representative of a biopolymeric data sequence and process the sequence of binary codes using instructions that are at least implicitly defined relative to at least one controlled sequence and representative of a biological event affecting one or more aspects of a biopolymeric molecule. A machine readable medium may contain a set of such instructions. The machine readable medium may be part of a genomics data processing system.
Inventor(s): Ganeshalingam; Lawrence (Dublin, CA), Allen; Patrick Nikita (Scotts Valley, CA)
Assignee: Annai Systems, Inc. (Los Gatos, CA)
Application Number:12/837,452
Patent Claims:1. An article of manufacture in a system for efficiently representing biopolymeric information, the article of manufacture comprising: a non-transitory machine readable medium containing a plurality of codes executable by a processor for causing the processor to: receive a nucleotide sequence associated with a biopolymeric molecule; determine differences between the nucleotide sequence and a controlled biopolymeric sequence wherein the differences correspond to biological events affecting one or more aspects of the biopolymeric molecule; generate, based upon the differences and using a defined instruction set, an instruction-encoded sequence of encoded instructions corresponding to a compressed representation of the nucleotide sequence wherein ones of the encoded instructions each include an opcode representative of a different one of the biological events and an operand relating to at least a portion of a monomer sequence of the biopolymeric molecule; and store the instruction-encoded sequence on a machine readable memory, wherein the instruction-encoded sequence is used for biological or genetic research or for medical purposes.

2. The article of manufacture of claim 1, wherein a position of at least one of the encoded instructions within the instruction-encoded sequence relates to a location within the nucleotide sequence.

3. The article of manufacture of claim 2, wherein the biopolymeric molecule comprises a DNA molecule and wherein the monomer sequence comprises at least a portion of a nucleotide base sequence of the DNA molecule.

4. The article of manufacture of claim 3, wherein the one of the biological events comprises a transition and the operand comprises at least a first nucleotide base.

5. The article of manufacture of claim 4, wherein the operand further comprises a second nucleotide base corresponding to a result of a transition of the first nucleotide base.

6. The article of manufacture of claim 3, wherein the one of the biological events comprises a deletion.

7. The article of manufacture of claim 3, wherein the one of the biological events comprises a transversion and the operand comprises at least a first nucleotide base.

8. The article of manufacture of claim 7, wherein the operand further comprises a second nucleotide base corresponding to a result of a transversion of the first nucleotide base.

9. The article of manufacture of claim 3, wherein the one of the biological events comprises a silent mutation and the operand comprises a first nucleotide base and a second nucleotide base.

10. The article of manufacture of claim 3, wherein the one of the biological events comprises a mis-sense mutation and the operand comprises at least a first nucleotide base.

11. The article of manufacture of claim 10, wherein the operand further comprises a second nucleotide base corresponding to a result of a mis-sense mutation of the first nucleotide base.

12. The article of manufacture of claim 3, wherein the one of the biological events comprises a non-sense mutation and the operand comprises at least a first nucleotide base.

13. The article of manufacture of claim 12, wherein the operand further comprises a second nucleotide base corresponding to a result of a non-sense mutation of the first nucleotide base.

14. The article of manufacture of claim 3, wherein the one of the biological events comprises an excision and the operand comprises a sequence length.

15. The article of manufacture of claim 3, wherein the one of the biological events comprises a cross-over and the operand comprises at least a sequence length.

16. The article of manufacture of claim 3, wherein the one of the biological events represented by a first of the plurality of instructions comprises a transition and the biological event represented by a second of the plurality of instructions comprises a transversion.

17. The article of manufacture of claim 16, wherein the biological event represented by a third of the plurality of instructions comprises a mis-sense mutation and the biological event represented by a fourth of the plurality of instructions comprises a non-sense mutation.

18. The article of manufacture of claim 17, wherein the biological event represented by a fifth of the plurality of instructions comprises a silent mutation and the biological event represented by a sixth of the plurality of instructions comprises an excision.

19. The article of manufacture of claim 3, wherein one or more of the plurality of instructions are used to create a delta representation of the nucleotide base sequence relative to the controlled biopolymeric sequence.

20. The article of manufacture of claim 19, wherein the delta representation is based at least in part upon modifications of nucleotide bases in the nucleotide base sequence relative to nucleotide bases of the controlled biopolymeric sequence.

21. The article of manufacture of claim 20, wherein the modifications include one of methylation, carboxylation, and formylation.

22. The article of manufacture of claim 20, wherein the modifications include a deamination.

23. The article of manufacture of claim 19, wherein the delta representation is based at least in part upon one or more structural differences between the DNA molecule and a controlled molecular structure.

24. The article of manufacture of claim 23, wherein the one or more structural differences relate to DNA packaging.

25. The article of manufacture of claim 23, wherein the one or more structural differences relate to chromatin structure.

26. The article of manufacture of claim 23, wherein the one or more structural differences relate to heterochromatin structure.

27. The article of manufacture of claim 1, wherein the one or more aspects include a monomer sequence of the biopolymeric molecule.

28. The article of manufacture of claim 1, wherein the one or more aspects include a structure of the biopolymeric molecule.

29. The article of manufacture of claim 1, wherein the biopolymeric molecule comprises an mRNA molecule.

30. The article of manufacture of claim 29, wherein the one of the biological events represented by one of the plurality of instructions comprises a splice and the operand identifies at least one intron or exon.

31. An apparatus for processing biopolymeric information, the apparatus comprising: a program memory for storing a plurality of machine-executable codes; and a processing engine configured to execute the machine-executable codes, the processing engine; receiving a nucleotide sequence associated with a biopolymeric molecule: determining differences between the nucleotide sequence and a controlled biopolymeric sequence wherein the differences correspond to ones of a plurality of biological events affecting aspects of the biopolymeric molecule; generating, based upon the differences and using a defined instruction set, an instruction-encoded sequence of encoded instructions corresponding to a compressed representation of the nucleotide sequence wherein ones of the encoded instructions each include an opcode representative of a different one of the plurality of biological events and an operand relating to at least a portion of a monomer sequence of the biopolymeric molecule; and storing the instruction-encoded sequence on a machine readable memory, wherein the instruction-encoded sequence is used for biological or genetic research or for medical purposes.

32. The apparatus of claim 31, wherein a position of at least one of the encoded instructions within the instruction-encoded sequence relates to a location within the nucleotide sequence.

33. The apparatus of claim 32, wherein the one of the plurality of biological events comprises a transition and the operand comprises at least a first nucleotide base.

34. The apparatus of claim 33, wherein the operand further comprises a second nucleotide base corresponding to a result of a transition of the first nucleotide base.

35. The apparatus of claim 32, wherein the one of the plurality of biological events comprises a deletion.

36. The apparatus of claim 32, wherein the one of the plurality of biological events comprises a transversion and the operand comprises at least a first nucleotide base.

37. The apparatus of claim 36, wherein the operand further comprises a second nucleotide base corresponding to a result of a transversion of the first nucleotide base.

38. The apparatus of claim 24, wherein the one of the plurality of biological events comprises a silent mutation and the operand comprises a first nucleotide base and a second nucleotide base.

39. The apparatus of claim 32, wherein the one of the plurality of biological events comprises a mis-sense mutation and the operand comprises at least a first nucleotide base.

40. The apparatus of claim 39, wherein the operand further comprises a second nucleotide base corresponding to a result of a mis-sense mutation of the first nucleotide base.

41. The apparatus of claim 32, wherein one of the plurality of biological events comprises a non-sense mutation and the operand comprises at least a first nucleotide base.

42. The apparatus of claim 41, wherein the operand further comprises a second nucleotide base corresponding to a result of a non-sense mutation of the first nucleotide base.

43. The apparatus of claim 32, wherein the one of the plurality of biological events comprises an excision and the operand comprises sequence length.

44. The apparatus of claim 32, wherein the one of the plurality of biological events comprises a cross-over and the operand comprises at least a sequence length.

45. The apparatus of claim 31, wherein the aspects include a monomer sequence of the biopolymeric molecule and a structure of the biopolymeric molecule.

46. The apparatus of claim 31, wherein the biolpolymeric molecule comprises a DNA molecule.

47. The apparatus of claim 46, wherein the biological event represented by a first of the plurality of instructions comprises a transition and the biological event represented by a second of the plurality of instructions comprises a transversion.

48. The apparatus of claim 47, wherein the biological event represented by a third of the plurality of instructions comprises a mis-sense mutation and the biological event represented by a fourth of the plurality of instructions comprises a non-sense mutation.

49. The apparatus of claim 48, wherein the biological event represented by a fifth of the plurality of instructions comprises a silent mutation and the biological event represented by a sixth of the plurality of instructions comprises an excision.

50. The apparatus of claim 46, wherein one or more of the plurality of instructions are used to create a delta representation of a nucleotide base sequence of the DNA molecule relative to the controlled biopolymeric sequence.

51. The apparatus of claim 50, wherein the delta representation is based at least in part upon modifications of nucleotide bases in the nucleotide base sequence relative to nucleotide bases of the controlled biopolymeric sequence.

52. The apparatus of claim 51, wherein the modifications include one of methylation, carboxylation, and formylation.

53. The apparatus of claim 5, wherein the modifications include deamination and base analog.

54. The apparatus of claim 50, wherein the delta representation is based at least in part upon one or more structural differences between the DNA molecule and a controlled molecular structure.

55. The apparatus of claim 54, wherein the one or more structural differences relate to DNA packaging.

56. The apparatus of claim 54, wherein the one or more structural differences relate to chromatin structure.

57. The apparatus of claim 54, wherein the one or more structural differences relate to a heterochromatin structure.

58. The apparatus of claim 31, wherein the biopolymeric molecule comprises an mRNA molecule.

59. The apparatus of claim 58, wherein the biological event represented by one of the plurality of instructions comprises a splice and the operand comprises at least one intron or exon.

60. A computer program product comprising a non-transitory computer readable medium including codes for causing a computer to: receive a sequence of binary codes representative of a biopolymeric data sequence; generate, by processing the sequence of binary codes using a plurality of instructions, an instruction-encoded sequence of encoded instructions corresponding to a compressed representation of the biopolymeric data sequence, each of the encoded instructions being representative of one of a plurality of biological events affecting one or more aspects of a biopolymeric molecule; wherein ones of the encoded instructions each include an opcode representative of one of the plurality of biological events and an operand relating to at least a portion of a monomer sequence of the biopolymeric molecule; and store the instruction-encoded sequence on a machine readable memory, wherein the instruction-encoded sequence is used for biological or genetic research or for medical purposes.

61. The computer program product of claim 60, wherein the codes further include codes for: defining one or more macro instructions comprised of two or more instructions of the plurality of instructions; and processing the sequence of binary codes using the one or more macro instructions.

62. The computer program product of claim 60, wherein the codes include codes for deriving a delta representation of the biopolymeric data sequence using a reference sequence.

63. The computer program product of claim 62, wherein the biopolymeric data sequence comprises a DNA sequence.

64. The computer program product of claim 63, wherein the delta representation is based at least upon differences between a nucleotide base sequence of the biopolymeric data sequence and a reference nucleotide base sequence of the reference sequence.

65. The computer program product of claim 64, wherein the delta representation is further based upon modifications of nucleotide bases in the nucleotide base sequence of the biopolymeric data sequence relative to nucleotide bases in the reference base sequence.

66. The computer program product of claim 60, wherein one or more of the plurality of instructions are used to represent a mutation in the biopolymeric data sequence.

67. A computer program product comprising a non-transitory computer readable medium including codes for causing a computer to: receive a sequence of binary codes representative of a biopolymeric data sequence; process the sequence of binary codes using a plurality of instructions in order to yield an instruction-encoded sequence of encoded instructions corresponding to a compressed representation of the biopolymeric data sequence, each of the plurality of instructions being representative of a biological event affecting one or more aspects of a biopolymeric molecule; wherein ones of the encoded instructions each include an opcode representative of one of the plurality of biological events and an operand relating to at least a portion of a monomer sequence of the biopolymeric molecule; and store the instruction-encoded sequence on a machine readable memory, wherein the instruction-encoded sequence is used for biological or genetic research or for medical purposes.

Details for Patent 8,412,462

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2030-06-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2030-06-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2030-06-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.